Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia) (CHO-CAP)

This study has been completed.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
G.A. de Wit, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00812084
First received: December 18, 2008
Last updated: June 11, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):